E2F1 is a Novel Fibrogenic Gene That Regulates Cholestatic Liver Fibrosis Through the Egr-1/SHP/EID1 Network

Overview

Journal Hepatology

Specialty Gastroenterology

Date 2014 Mar 13

PMID 24619556

Citations 68

Authors

Yuxia Zhang

Ningyi Xu

Jun Xu

Bo Kong

Bryan Copple

Grace L Guo

Li Wang

Affiliations

Soon will be listed here.

Abstract

Unlabelled: E2F transcription factor 1 (E2F1) is an important regulator of metabolic diseases; however, its role in liver function remains elusive. This study unraveled a regulatory cascade involving E2F1, early growth response-1 (Egr-1), nuclear receptor small heterodimer partner (SHP, NR0B2), and EIA-like inhibitor of differentiation 1 (EID1) in cholestatic liver fibrosis. Liver E2F1 messenger RNA (mRNA) and protein expression was strongly up-regulated in human nonalcoholic steatohepatitis (NASH) and alcohol cirrhosis; the latter was inversely correlated with diminished SHP expression. E2F1 was also highly induced by 3,5-diethoxycarbonyl-1, 4-dihydrocollidine (DDC) feeding and bile-duct ligation (BDL) in mice. E2F1-/- mice exhibited reduced biliary fibrosis by DDC as determined by Masson Trichrome and Picro Sirius red staining, and decreased serum bile acid (BA), BA pool size, and fecal BA excretion. In addition, cholestatic liver fibrosis induced by BDL, as determined by immunohistochemistry analysis of a1 collagen expression, was increased in SHP-/- mice but attenuated in hepatocyte SHP-overexpressed transgenic (STG) mice. Egr-1 exhibited marked induction in livers of SHP-/- mice compared to the wild-type mice in both sham and BDL groups, and reduction in STG livers. Egr-1 promoter was activated by E2F1, and the activation was abrogated by expression of SHP and its co-repressor EID1 in hepatoma cells Huh7, Hepa1, and stellate cells LX2. Chromatin immunoprecipitation assays further confirmed the association of E2F1, SHP, and EID1 proteins with the Egr-1 promoter, and their direct protein interactions were determined by glutathione S-transferase pull-down assays. Interestingly, E2F1 activated Egr-1 expression in a biphasic fashion as described in both human and mouse hepatocytes.

Conclusion: E2F1 is a fibrogenic gene and could serve as a potential new diagnostic marker for nonalcoholic and alcoholic liver fibrosis/cirrhosis.

Citing Articles

Promotion of nonalcoholic steatohepatitis by RNA N-methyladenosine reader IGF2BP2 in mice.

Zhou B, Luo Y, Ji N, Mao F, Xiang L, Bian H Life Metab. 2025; 1(2):161-174.

PMID: 39872354 PMC: 11749640. DOI: 10.1093/lifemeta/loac006.

Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis.

Zhu W, Li X, Xie J, Lu Q, Ma Y, Zhu Z World J Hepatol. 2025; 17(1):96105.

PMID: 39871895 PMC: 11736489. DOI: 10.4254/wjh.v17.i1.96105.

Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Zou X, Brigstock D Biomedicines. 2025; 12(12.

PMID: 39767754 PMC: 11673942. DOI: 10.3390/biomedicines12122848.

Proteomics reveals the key transcription-related factors mediating obstructive nephropathy in pediatric patients and mice.

Cao H, Tao Y, Jin R, Li P, Zhou H, Cheng J Ren Fail. 2025; 47(1):2443032.

PMID: 39743726 PMC: 11703465. DOI: 10.1080/0886022X.2024.2443032.

restrains an oncogenic circuit in AT2 cells to prevent fibrogenic cell intermediates in pulmonary fibrosis.

Seasock M, Shafiquzzaman M, Ruiz-Echartea M, Kanchi R, Tran B, Simon L bioRxiv. 2024; .

PMID: 38826218 PMC: 11142151. DOI: 10.1101/2024.05.22.595205.

References

Friedman S . Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134(6):1655-69. PMC: 2888539. DOI: 10.1053/j.gastro.2008.03.003. View

Aguilar V, Fajas L . Cycling through metabolism. EMBO Mol Med. 2010; 2(9):338-48. PMC: 3118222. DOI: 10.1002/emmm.201000089. View

Zhang Y, Xu P, Park K, Choi Y, Moore D, Wang L . Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology. 2008; 48(1):289-98. PMC: 3800167. DOI: 10.1002/hep.22342. View

Kovesdi I, Reichel R, Nevins J . Identification of a cellular transcription factor involved in E1A trans-activation. Cell. 1986; 45(2):219-28. DOI: 10.1016/0092-8674(86)90386-7. View

Zhang Y, Wang L . Characterization of the mitochondrial localization of the nuclear receptor SHP and regulation of its subcellular distribution by interaction with Bcl2 and HNF4α. PLoS One. 2013; 8(7):e68491. PMC: 3706418. DOI: 10.1371/journal.pone.0068491. View

Wang L, Han Y, Kim C, Lee Y, Moore D . Resistance of SHP-null mice to bile acid-induced liver damage. J Biol Chem. 2003; 278(45):44475-81. DOI: 10.1074/jbc.M305258200. View

Allen K, Kim N, Moon J, Copple B . Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol. 2009; 243(1):63-7. PMC: 2819615. DOI: 10.1016/j.taap.2009.11.013. View

Zhang Y, Hagedorn C, Wang L . Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta. 2010; 1812(8):893-908. PMC: 3043166. DOI: 10.1016/j.bbadis.2010.10.006. View

Allen K, Jaeschke H, Copple B . Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol. 2011; 178(1):175-86. PMC: 3070591. DOI: 10.1016/j.ajpath.2010.11.026. View

10.

Kim N, Moon J, Slitt A, Copple B . Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci. 2006; 90(2):586-95. DOI: 10.1093/toxsci/kfj111. View

11.

Zhang Y, Bonzo J, Gonzalez F, Wang L . Diurnal regulation of the early growth response 1 (Egr-1) protein expression by hepatocyte nuclear factor 4alpha (HNF4alpha) and small heterodimer partner (SHP) cross-talk in liver fibrosis. J Biol Chem. 2011; 286(34):29635-43. PMC: 3191004. DOI: 10.1074/jbc.M111.253039. View

12.

Patel T, Gores G . Apoptosis and hepatobiliary disease. Hepatology. 1995; 21(6):1725-41. DOI: 10.1002/hep.1840210635. View

13.

Lim C, Yao F, Wong J, George J, Xu H, Chiu K . Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol Cell. 2007; 27(4):622-35. DOI: 10.1016/j.molcel.2007.06.038. View

14.

Blanchet E, Annicotte J, Fajas L . Cell cycle regulators in the control of metabolism. Cell Cycle. 2009; 8(24):4029-31. PMC: 3323501. DOI: 10.4161/cc.8.24.10110. View

15.

Zhang Y, Andrews G, Wang L . Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP. Nucleic Acids Res. 2012; 40(11):4850-60. PMC: 3367194. DOI: 10.1093/nar/gks159. View

16.

Bavner A, Johansson L, Toresson G, Gustafsson J, Treuter E . A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP. EMBO Rep. 2002; 3(5):478-84. PMC: 1084100. DOI: 10.1093/embo-reports/kvf087. View

17.

Park Y, Qatanani M, Chua S, Larey J, Johnson S, Watanabe M . Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis. Hepatology. 2008; 47(5):1578-86. DOI: 10.1002/hep.22196. View

18.

Zeisberg M, Yang C, Martino M, Duncan M, Rieder F, Tanjore H . Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem. 2007; 282(32):23337-47. DOI: 10.1074/jbc.M700194200. View

19.

Mann D, Smart D . Transcriptional regulation of hepatic stellate cell activation. Gut. 2002; 50(6):891-6. PMC: 1773234. DOI: 10.1136/gut.50.6.891. View

20.

Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall H, Weiglein A . A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol. 2007; 171(2):525-36. PMC: 1934539. DOI: 10.2353/ajpath.2007.061133. View